Jared Moskowitz · ABBV
Jared Moskowitz's ABBV trades
- Transactions
- 3
- Buys / sells
- 3 / 0
- Disclosed range
- $3K – $45K
- Last filed
- 2025-05-09
ABBV transactions reported by Jared Moskowitz
| Type | Owner | ||||
|---|---|---|---|---|---|
AbbVie Inc. Common Stock ABBV | Purchase | Self | $1,001 - $15,000 | 2025-05-09 #20030282 | |
AbbVie Inc. Common Stock ABBV | Purchase | Dependent | $1,001 - $15,000 | 2025-02-10 #20026731 | |
AbbVie Inc. Common Stock ABBV | Purchase | Self | $1,001 - $15,000 | 2025-02-10 #20026731 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
The tracker is free
A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.
Other House members who reported ABBV
More tickers reported by Jared Moskowitz
Jared Moskowitz and ABBV — questions
Did Jared Moskowitz buy or sell ABBV?
House Clerk filings for 2025 and 2026 show 3 purchases and 0 sales of AbbVie Inc. (ABBV) reported by Jared Moskowitz, between 2025-01-15 and 2025-04-07. Reported owners: Self, Dependent.
How much ABBV did Jared Moskowitz trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K – $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last ABBV filing by Jared Moskowitz?
The most recent periodic transaction report containing a ABBV row was filed on 2025-05-09. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with AbbVie Inc.. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Jared Moskowitz ABBV disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included